| 000 | 01076 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516191316.0 | ||
| 264 | 0 | _c20140916 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1538-7836 | ||
| 024 | 7 |
_a10.1111/jth.12445 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSiller-Matula, J M | |
| 245 | 0 | 0 |
_aClinical implications of drug-drug interactions with P2Y12 receptor inhibitors. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _cJan 2014 |
||
| 300 |
_a2-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCytochromes _xmetabolism |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPurinergic Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2Y12 _xdrug effects |
| 700 | 1 | _aTrenk, D | |
| 700 | 1 | _aKrähenbühl, S | |
| 700 | 1 | _aMichelson, A D | |
| 700 | 1 | _aDelle-Karth, G | |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 12 _gno. 1 _gp. 2-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jth.12445 _zAvailable from publisher's website |
| 999 |
_c23431767 _d23431767 |
||